Seminars in Oncology
Volume 33 , Pages S41-S49 , October 2006

Future Directions in Vascular Endothelial Growth Factor–Targeted Therapy for Metastatic Colorectal Cancer

  • Axel Grothey

      Affiliations

    • Dr Grothey has served as a consultant to Pfizer, Genentech, and AstraZeneca.
    • Corresponding Author InformationAddress reprint requests to Axel Grothey, MD, Division of Medical Oncology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(06)00315-0

doi: 10.1053/j.seminoncol.2006.08.004

Seminars in Oncology
Volume 33 , Pages S41-S49 , October 2006

Article Tools

* Image Usage & Resolution